// App-Quantinova.ai

: Liver Transplantation for Non-Resectable Colorectal Liver Metastases: The International Hepato-Pancreato-Biliary Association Consensus Guidelines

Researchers

Presenter

  • C.A. Chew

Principal Investigators

  • P. Trunecka

  • K. Halazun

  • J. Hubbard

  • C.E. Chee

  • D. Mirza

  • S. Dueland

  • P.-D. Line

  • R. Adam

  • G.K. Bonney

Medical Centers

  • Oslo University Hospital, Department of Transplantation Medicine, Oslo, NORWAY

  • Institute for Clinical and Experimental Medicine, Department of Gastroenterology and Hepatology, Prague, Czech Republic

  • Weill Cornell Medicine, Division of Liver Transplantation & HPB Surgery, Department of Surgery, New York, United States

  • Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust (UHBFT), Liver Unit, Birmingham, United Kingdom

  • National University Hospital Singapore, Division of Hepatobiliary Surgery, Singapore, Singapore

  • Mayo Clinic, Department of Medical Oncology, Rochester, United States

  • AP-HP Paul Brousse Hospital, University Paris-Saclay, Hepato Biliary Surgery, Cancer and Transplantation Unit, Paris, France

  • National University Cancer Institute, Department of HematologyOncology, Singapore, Singapore

Locations

  • Norway

  • Singapore

  • Czech Republic

  • United States

  • France

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • Colorectal liver metastases

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved